Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contrast Enhanced Ultrasound for Assessment of Carotid Artery Neovascularization as a Marker of Disease Activity in Takayasu's Arteritis and Giant Cell Arteritis

NCT01795456 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT01795456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01795456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contrast Enhanced Ultrasound for Assessment of Carotid Artery Neovascularization as a Marker of Disease Activity in Takayasu's Arteritis and Giant Cell Arteritis
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
January 31, 2014
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortitis, arteritis, giant cell arteritis, takayasu's arteritis, vasculitis